Rn for treatment of periocular fibrous connective tissue sarcomas in the horse.
Twelve periocular fibrous connective tissue sarcomas in 11 horses were treated with 222Rn. Follow-up periods ranged from 1 to 6 years; the overall nonrecurrence rate at 12 months after therapy was 92%. Two lesions recurred 2 years after treatment, and 1 after 3 years. One of the former lesions has not recurred after a 2nd 222Rn treatment.
D000818:Animals; D005142:Eyelid Neoplasms / Q000532:radiotherapy / Q000662:veterinary*; D005354:Fibrosarcoma / Q000532:radiotherapy / Q000662:veterinary*; D006734:Horse Diseases / Q000532:radiotherapy*; D006736:Horses; D009364:Neoplasm Recurrence, Local; D011886:Radon / Q000627:therapeutic use*
D011886:Radon